Annual Current Ratio
12.73
+8.63+210.49%
December 31, 2023
Summary
- As of February 8, 2025, VYNE annual current ratio is 12.73, with the most recent change of +8.63 (+210.49%) on December 31, 2023.
- During the last 3 years, VYNE annual current ratio has risen by +8.72 (+217.46%).
- VYNE annual current ratio is now -77.66% below its all-time high of 56.99, reached on December 31, 2015.
Performance
VYNE Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Ratio
5.81
-1.32-18.51%
September 30, 2024
Summary
- As of February 8, 2025, VYNE quarterly current ratio is 5.81, with the most recent change of -1.32 (-18.51%) on September 30, 2024.
- Over the past year, VYNE quarterly current ratio has dropped by -1.32 (-18.51%).
- VYNE quarterly current ratio is now -69.68% below its all-time high of 19.16, reached on September 30, 2018.
Performance
VYNE Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
VYNE Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +210.5% | -18.5% |
| 3 y3 years | +217.5% | +41.7% |
| 5 y5 years | -12.9% | +41.7% |
VYNE Current Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +271.1% | -55.4% | +113.6% |
| 5 y | 5-year | at high | +271.1% | -55.4% | +233.9% |
| alltime | all time | -77.7% | +271.1% | -69.7% | +233.9% |
VYNE Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 5.81(-18.5%) |
| Jun 2024 | - | 7.13(-45.2%) |
| Mar 2024 | - | 13.02(+2.3%) |
| Dec 2023 | 12.73(+210.5%) | 12.73(+368.0%) |
| Sep 2023 | - | 2.72(-24.4%) |
| Jun 2023 | - | 3.60(-18.0%) |
| Mar 2023 | - | 4.39(+7.1%) |
| Dec 2022 | 4.10(+19.5%) | 4.10(-36.3%) |
| Sep 2022 | - | 6.44(-15.3%) |
| Jun 2022 | - | 7.60(+7.6%) |
| Mar 2022 | - | 7.06(+105.8%) |
| Dec 2021 | 3.43(-14.5%) | 3.43(-5.5%) |
| Sep 2021 | - | 3.63(+62.8%) |
| Jun 2021 | - | 2.23(-66.4%) |
| Mar 2021 | - | 6.64(+65.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | 4.01(-45.4%) | 4.01(-5.2%) |
| Sep 2020 | - | 4.23(-14.0%) |
| Jun 2020 | - | 4.92(+182.8%) |
| Mar 2020 | - | 1.74(-76.3%) |
| Dec 2019 | 7.35(-49.7%) | 7.35(-25.6%) |
| Sep 2019 | - | 9.88(+4.0%) |
| Jun 2019 | - | 9.50(-19.4%) |
| Mar 2019 | - | 11.78(-19.4%) |
| Dec 2018 | 14.62(+78.9%) | 14.62(-23.7%) |
| Sep 2018 | - | 19.16(+6.1%) |
| Jun 2018 | - | 18.06(-4.2%) |
| Mar 2018 | - | 18.85(+130.7%) |
| Dec 2017 | 8.17(+1.1%) | 8.17(-22.1%) |
| Sep 2017 | - | 10.49(+29.8%) |
| Dec 2016 | 8.08(-85.8%) | 8.08 |
| Dec 2015 | 56.99 | - |
FAQ
- What is VYNE Therapeutics annual current ratio?
- What is the all time high annual current ratio for VYNE Therapeutics?
- What is VYNE Therapeutics annual current ratio year-on-year change?
- What is VYNE Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for VYNE Therapeutics?
- What is VYNE Therapeutics quarterly current ratio year-on-year change?
What is VYNE Therapeutics annual current ratio?
The current annual current ratio of VYNE is 12.73
What is the all time high annual current ratio for VYNE Therapeutics?
VYNE Therapeutics all-time high annual current ratio is 56.99
What is VYNE Therapeutics annual current ratio year-on-year change?
Over the past year, VYNE annual current ratio has changed by +8.63 (+210.49%)
What is VYNE Therapeutics quarterly current ratio?
The current quarterly current ratio of VYNE is 5.81
What is the all time high quarterly current ratio for VYNE Therapeutics?
VYNE Therapeutics all-time high quarterly current ratio is 19.16
What is VYNE Therapeutics quarterly current ratio year-on-year change?
Over the past year, VYNE quarterly current ratio has changed by -1.32 (-18.51%)